Acute Porphyria Drug Database

D10AX03 - Azelaic Acid
Possibly porphyrinogenic
PSP

Rationale
Endogenous organic acid with significant systemic exposure in dermal use
Chemical description
(To be edited, initial data ST OCT 04) Azelaic acid, endogenous antibacterial substance in creme 200 mg mg / g for dermal use twice daily in acne of moderate severity. Less than 5 % is absorbed through the skin. Urinary excretion is stated to be 25 mg/24 h.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes D10A / D10AX or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙